Gregory Reinholz
About Gregory Reinholz
Gregory Reinholz is a Staff Scientist at HTG Molecular Diagnostics, with a diverse background in research spanning several prestigious institutions including the Mayo Clinic and Covance Laboratories. He holds a Ph.D. in Biochemistry and specializes in cancer biology, regenerative medicine, and molecular biology.
Current Role at HTG Molecular Diagnostics
Gregory Reinholz serves as a Staff Scientist at HTG Molecular Diagnostics, a position he has held since 2018. His work is based in the Tucson, Arizona Area. In this role, he contributes to the development and implementation of innovative molecular diagnostic solutions. His responsibilities include designing experiments, analyzing data, and collaborating with cross-functional teams to advance the company's research objectives.
Previous Experience at Covance Laboratories
Prior to his current role, Gregory Reinholz worked at Covance Laboratories as a Research Assistant from 1986 to 1992. During his six years there, he gained foundational experience in laboratory research and contributed to various projects that supported the company’s mission in drug development and testing.
Tenure at Mayo Clinic
Gregory Reinholz had an extensive tenure at Mayo Clinic, where he held multiple positions. He served as Co-Director of the Cartilage and Connective Tissue Research Laboratory from 2001 to 2009. Additionally, he was a Research Fellow/Senior Research Fellow from 1998 to 2001, a Professional Associate in Research from 2006 to 2011, and an Assistant Professor from 2005 to 2011. His work at Mayo Clinic focused on advancing research in cartilage and connective tissue, contributing significantly to the understanding of related diseases.
Educational Background in Molecular Biology and Biochemistry
Gregory Reinholz earned his Bachelor of Science (BS) in Molecular Biology from the University of Wisconsin-Madison, where he studied from 1982 to 1986. He later pursued a Doctor of Philosophy (Ph.D.) in Biochemistry at the same institution, completing his studies from 1992 to 1998. His educational background provides a strong foundation for his research and scientific endeavors.
Expertise in Research and Development
Gregory Reinholz possesses extensive expertise in various scientific domains, including cancer biology, tumor-induced bone diseases, osteoporosis, osteoarthritis, and regenerative medicine. He has a strong understanding of Good Distribution Practice (GDP), Good Laboratory Practice (GLP), and In Vitro Diagnostic Companion Diagnostics (IVD/CDx) product development design control. His skills encompass project management, laboratory techniques, and the generation and administration of research grants.